{"id":8365,"date":"2020-12-11T11:17:29","date_gmt":"2020-12-11T11:17:29","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=8365"},"modified":"2020-12-11T12:10:11","modified_gmt":"2020-12-11T12:10:11","slug":"a-scottish-aquaculture-startup-wins-contract-to-support-alternative-protein-trials","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/a-scottish-aquaculture-startup-wins-contract-to-support-alternative-protein-trials\/8365\/","title":{"rendered":"A Scottish aquaculture startup wins contract to support alternative protein trials"},"content":{"rendered":"
Using a gut simulator that mimics the digestive tract of Atlantic salmon, SalmoSim<\/a> will conduct a trial of Calysta<\/a>\u2019s single-cell feed ingredient FeedKind protein, which is made by fermenting natural gas. FeedKind has been developed to meet the growing global demand for nutrients and is designed to be a sustainable alternative protein source for aquaculture.<\/p>\n SalmoSim will use its gut simulator equipment to support Calysta\u2019s product quality programme while also testing a number of variables in support of new product development. Results from the simulation, taking place at the University of Glasgow, will provide Calysta with valuable data on digestibility comparing FeedKind in SalmoSim to existing in vivo<\/em> data.<\/p>\n Dr Martin Llewellyn, founder of SalmoSim and senior lecturer at the University of Glasgow, said: \u201cOur gut simulation system provides a powerful tool for carrying out basic and applied research into fish digestion and we\u2019re pleased to be supporting Calysta with the development of its alternative protein. In this case, we\u2019ll be looking specifically at batch control to provide data that will support the full-scale manufacturing of FeedKind.<\/p>\n